The S&P 500 (SPX) has surpassed its previous high among a global pandemic and an uncertain economy. The index is up almost 11% year-to-date, as investors anticipate more good news regarding a COVID-19 vaccine. Nonetheless, it proved a strange week in price action terms as Monday’s 4% gap up was almost erased by the end of the day. When the…
Get Back Up: Now, What Did You Learn?
A financial market resource for the every-day investor and trader.
-
J.P. Morgan: What was I made for: Large Language Models in the Real World
Seth Golden, , Research Reports, 0
On markets, not much has changed since our August Rasputin piece. While most leading indicators point to weaker US...
-
A 9% Correction & Earnings Beats Warrant Nibbling
Seth Golden, , Research Reports, 0
Correction right on schedule.2 weeks ago we called for a second 10% correction in as many months as we...
-
The Leuthold Group: Jay Powell, The Chartist
Seth Golden, , Research Reports, 0
By: Doug Ramsey Chief Investment Officer & Portfolio Manager Doug is the Chief Investment Officer of The Leuthold Group, LLC,...
-
Merrill Lynch: How tight are financial conditions?
Seth Golden, , Research Reports, 0
No Clear Path to Easier Financial Conditions Financial conditions are a key transmission mechanism for monetary policy and geopolitical...
-
Relief Rally Over or Game On?
Seth Golden, , Research Reports, 2
On behalf of Finom Group, we want to wish everyone a happy and healthy holiday weekend. As mentioned in...
-
Macy’s May Be Acquired, But It Begs For Greater Logic
Seth Golden, , Research Reports, 0
A rumor has recently surfaced regarding the possibility, not the probability, but the possibility of Macy’s (M) selling itself....
-
Costco Shares Have Been Poorly Received By Investors
Seth Golden, , Research Reports, 0
Costco (COST) reported 4th quarter results that showed a surprising beat on the bottom line. Initially, the stock reacted with a nearly...
-
J.P. Morgan MacroView Into Q3 2021 Quarter-End
Seth Golden, , Research Reports, 0
Markets to continue following the path of COVID recovery Cross-asset Strategy: Risk markets recovered from the technical sell-off, as...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00